An observational study of pain severity, cannabis use, and benefit expenditures in work disability
-
Published:2023-10-16
Issue:
Volume:
Page:
-
ISSN:0008-4263
-
Container-title:Canadian Journal of Public Health
-
language:en
-
Short-container-title:Can J Public Health
Author:
Mustard Cameron A.ORCID, Orchard Christa, Dobson Kathleen G.ORCID, Carnide NancyORCID, Smith Peter M.ORCID
Abstract
Abstract
Objective
This study pools two cohorts of workers in Ontario interviewed 18 months following a disabling work-related injury to estimate the association between pain severity, cannabis use, and disability benefit expenditures.
Methods
Among 1650 workers, disability benefit expenditures obtained from administrative records were combined with self-reported measures of pain symptoms and cannabis use. Disability benefit expenditures comprised wage replacement benefits and expenditures on healthcare services.
Results
Past-year cannabis use was reported by 31% of participants, with approximately one third of cannabis use attributed to the treatment of conditions arising from the work-related injury. Condition-related cannabis use was elevated among the 34% of participants reporting severe pain symptoms. In regression models adjusted for age, sex, nature of injury, opioid prescription, and pre-injury chronic conditions, participants reporting condition-related cannabis use had equivalent wage replacement benefit expenditures (β = 0.254, ns) and higher healthcare benefit expenditures (β = 0.433, p = 0.012) compared to participants who did not use cannabis. Participants reporting cannabis use unrelated to conditions arising from their work-related injury had lower wage replacement benefit expenditures (β = − 0.309, p = 0.002) and equivalent healthcare benefit expenditures (β = − 0.251, ns) compared to participants not using cannabis.
Conclusion
This novel study of workers’ compensation claimants interviewed at 18 months post-injury did not observe a substantial relationship between cannabis use and disability benefit expenditures, suggesting that neither harm nor significant benefit is associated with cannabis use. These findings contribute to understanding the potential benefits and risks associated with cannabis use in settings that have legalized cannabis use.
Funder
Workplace Safety and Insurance Board
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,General Medicine
Reference32 articles.
1. Alkassabi, O., Voogt, L., Andrews, P., Alhowimel, A., Nijs, J., & Alsobayel, H. (2022). Risk factors to persistent pain following musculoskeletal injuries: A systematic literature review. International Journal of Environmental Research and Public Health, 19(15), 9318. https://doi.org/10.3390/ijerph19159318 2. Baragaba, B., Alghnam, S., & Bernacki, E. J. (2016). Work-related injuries and health-related quality of life among US workers: A longitudinal study of a population-based sample. Journal of Occupational and Environmental Medicine, 58(4), 385–390. https://doi.org/10.1097/JOM.0000000000000667 3. Bialas, P., Fitzcharles, M. A., Klose, P., & Häuser, W. (2022). Long-term observational studies with cannabis-based medicines for chronic non-cancer pain: A systematic review and meta-analysis of effectiveness and safety. European Journal of Pain, 26(6), 1221–1233. https://doi.org/10.1002/ejp.1957 4. Campbell, G., Hall, W. D., Peacock, A., Lintzeris, N., Bruno, R., Larance, B., Nielsen, S., Cohen, M., Chan, G., Mattick, R. P., Blyth, F., Shanahan, M., Dobbins, T., Farrell, M., & Degenhardt, L. (2018). Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: Findings from a 4-year prospective cohort study. Lancet Public Health., 3(7), e341–e350. https://doi.org/10.1016/S2468-2667(18)30110-5 5. Carnide, N., Lee, H., Frone, M. R., Furlan, A. D., & Smith, P. M. (2021). Patterns and correlates of workplace and non-workplace cannabis use among Canadian workers before the legalization of non-medical cannabis. Drug and Alcohol Dependence, 1(218), 108386. https://doi.org/10.1016/j.drugalcdep.2020.108386
|
|